CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy and safety of infliximab in patients with ulcerative colitis refractory to steroids and immunosuppressive agents
DOI 10.1055/s-0028-1096438
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Jürgens, T Ochsenkühn, S Brand, S Pfennig, C Tillack, B Göke, J Seiderer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe10/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Infliximab (IFX; Remicade, Schering Plough), a chimeric monoclonal antibody targeting TNF-α, represents the first biological approved for treatment of ulcerative colitis (UC). In order to evaluate the efficacy and safety of IFX in UC, we retrospectively analyzed the effect of IFX on induction and maintenance of remission, prevention of colectomy and safety in UC patients, refractory to steroids and imm…
Zitieren
Zitierempfehlung
M Jürgens, T Ochsenkühn, S Brand, S Pfennig, C Tillack, B Göke, J Seiderer (2008) Efficacy and safety of infliximab in patients with ulcerative colitis refractory to steroids and immunosuppressive agents. Zeitschrift für Gastroenterologie (10). https://doi.org/10.1055/s-0028-1096438
Mit CareLit weiterarbeiten